Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja Organon Pharma Indonesia Tbk. (SCPI) vs Pelayaran Tamarin Samudra Tbk. (TAMU)

Organon Pharma Indonesia Tbk.Trading
Pelayaran Tamarin Samudra Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Organon Pharma Indonesia Tbk. dan Pelayaran Tamarin Samudra Tbk.: Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M), sedangkan Pelayaran Tamarin Samudra Tbk. diperdagangkan di Rp28 (kapitalisasi pasar 1,05 T, volume 24 jam 10,88 jt). Perbedaan utamanya: Pelayaran Tamarin Samudra Tbk. jauh lebih besar — sekitar 10,1× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.

SCPITAMU
Kapitalisasi Pasar
104,4 M1,05 T
Volume
10,88 jt
Lot
108,83 rb
Perputaran
300,23 jt
Harga Rata-rata
27,59
Nilai Transaksi
300,23 jt
Harga Ekuilibrium Indikatif
28
Volume Ekuilibrium Indikatif
8,09 rb

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

SCPI
Lihat detail
TAMU
Lihat detail

Tentang Organon Pharma Indonesia Tbk.

PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.

Selengkapnya di halaman SCPI

Tentang Pelayaran Tamarin Samudra Tbk.

PT Pelayaran Tamarin Samudra Tbk (the Company) was established based on the Deed of Notary Linda Ibrahim, SH, No. 38 dated August 27, 1998. The company services are include offshore marine support such as chartering, re-chartering and transshipment services of Accommodation Work Barge (AWB), Anchor Handling Towing Supply (AHTS).

Selengkapnya di halaman TAMU